Continuing Education

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and Healthcare Association of New York State. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education and American Nurses Credentialing Center to provide continuing education for the healthcare team.

 

This activity was planned by and for the healthcare team, and learners will receive 10.0 Interprofessional Continuing Education credit for learning and change.

Credit designation for pharmacists

This application-based activity is approved for a maximum of 10.0 contact hours of continuing pharmacy education credit (JA4008106-9999-23-001-L05-P).

Credit designation for nursing

AXIS Medical Education designates this continuing nursing education activity for 10.0 contact hours.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Quality professionals

This program has been approved by the National Association for Healthcare Quality for a maximum of 10.0 CPHQ continuing education credits for this event.

AXIS contact information

For information about the accreditation of this program, please contact AXIS at info@axismeded.org.

Disclosure of conflicts of interest

AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity.

AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by staff, planners, faculty/authors, peer reviewers or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers and/or relevant staff is provided with this activity.

The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:

Name of faculty/presenter Reported financial relationship
Carolyn Candiello, MA, CPHRM Nothing to disclose
John Chessare, MD, MPH, FAAP, FACHE Nothing to disclose
Tim Cunningham, RN, DrPH, FAAN Nothing to disclose
Barbara Delmore, PhD, RN, CWCN, MAPWCA, IIWCC-NYU, FAAN Nothing to disclose
Anna Legreid Dopp, PharmD, CPHQ Common stock: Merck
Linda R. Greene, RN, MPS, CIC, FAPIC Nothing to disclose
Charlene Ludlow, RN, BSN, MHA, CIC Nothing to disclose
Patricia A. McGaffigan, MS, RN, CPPS Nothing to disclose
Patricia Quigley, PhD, MPH, APRN, CRRN, FAAN, FAANP, FARN, ARN Independent Contractor: Curbell Medical Products, Inc.
Kathleen Rauch, RN, MSHQS, BSN, CPHQ Nothing to disclose
Maureen Seckel, APRN, MSN, ACNS-BC, CCNS, CCRN-K, FCNS, FCCM, FAAN Nothing to disclose

The following directors, planners, managers and reviewers reported no financial relationships they have with any ineligible company of any amount during the past 24 months:

Name of directors, planners, managers and reviewers
Kristina Catrambone, CMP, CGMP
Holly M. Hampe, DSc, RN, MHA, MRM, CPHQ
Lindsay Milchteim, MPH, PCMH CCE
Dee Morgillo, MEd, MT(ASCP), CHCP
Cathleen R. Wright, DNS, RN

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

Requirements for credit

  • Attend/participate in the educational activity and review all course materials.
  • Complete the CE Attestation/Evaluation form online by 11:59 p.m. ET on March 8, 2023. Instructions will be provided. If you do not complete the online evaluation by this date, you will not be able to get CE credit for this event.
  • Upon successful completion of the online form, your statement of completion will be presented to you to print. Pharmacists, your record will be automatically uploaded to CPE Monitor.